- Patent Title: Anti-huLRRC15 antibody drug conjugates and methods for their use
-
Application No.: US15363715Application Date: 2016-11-29
-
Publication No.: US10188660B2Publication Date: 2019-01-29
- Inventor: Kurt C. Gish , Jonathan A. Hickson , Susan Elizabeth Morgan-Lappe , James W. Purcell
- Applicant: AbbVie Inc. , AbbVie Biotherapeutics Inc.
- Applicant Address: US IL North Chicago US CA Redwood City
- Assignee: AbbVie Inc.,AbbVie Biotherapeutics Inc.
- Current Assignee: AbbVie Inc.,AbbVie Biotherapeutics Inc.
- Current Assignee Address: US IL North Chicago US CA Redwood City
- Agency: Dechert LLP
- Main IPC: A61K38/07
- IPC: A61K38/07 ; A61K31/5517 ; C07K16/30 ; A61K47/06 ; A61K39/395 ; C07K16/28 ; A61K47/68 ; A61K39/00
Abstract:
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
Public/Granted literature
- US20170151343A1 ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE Public/Granted day:2017-06-01
Information query
IPC分类:
